Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Certified by Founder
Lodge
Inspire Biotherapeutics Inc
start up
Canada
- Toronto, Ontario
- 17/03/2023
- Pre-Seed
- Undisclosed Amount
Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. We are currently pursing initiation of a Proof-of-Concept clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis and other monogenic lung diseases.
- Industry Biotechnology Research
- Website https://www.inspirebiotx.com/
- LinkedIn https://www.linkedin.com/company/inspire-biotherapeutics-inc/people/
Related People
Sandra DonaldsonFounder
Canada -
Toronto, Ontario
VP & COO OIRM. CEO & COO, Inspire Biotherapeutics. Experienced executive with a demonstrated history of nurturing research networks into thriving ecosystems while working in biotechnology and clinical trial sectors.
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)